CINECA IRIS Institutional Research Information System

CIRCOSTA, Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.744
NA - Nord America 1.760
AS - Asia 899
AF - Africa 105
SA - Sud America 39
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 7
Totale 6.581
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.709
DE - Germania 1.703
IT - Italia 502
FR - Francia 456
CN - Cina 270
IN - India 240
GB - Regno Unito 144
PL - Polonia 140
CZ - Repubblica Ceca 115
NL - Olanda 103
GR - Grecia 93
RU - Federazione Russa 80
JP - Giappone 70
ID - Indonesia 64
KR - Corea 47
SE - Svezia 46
RO - Romania 44
CA - Canada 41
CH - Svizzera 41
ES - Italia 40
HK - Hong Kong 39
UA - Ucraina 38
VN - Vietnam 37
FI - Finlandia 35
NG - Nigeria 24
HR - Croazia 23
ZA - Sudafrica 22
IR - Iran 20
BR - Brasile 19
PT - Portogallo 17
SG - Singapore 17
TW - Taiwan 16
AU - Australia 15
TR - Turchia 15
BE - Belgio 14
BG - Bulgaria 14
IE - Irlanda 14
PK - Pakistan 14
AT - Austria 13
DZ - Algeria 13
CI - Costa d'Avorio 12
NZ - Nuova Zelanda 12
EG - Egitto 10
MX - Messico 9
MK - Macedonia 8
RS - Serbia 8
CL - Cile 7
MA - Marocco 7
PH - Filippine 7
A1 - Anonimo 6
IL - Israele 6
SI - Slovenia 6
AR - Argentina 5
AZ - Azerbaigian 5
DK - Danimarca 5
EE - Estonia 5
GH - Ghana 5
HU - Ungheria 5
LV - Lettonia 5
SK - Slovacchia (Repubblica Slovacca) 5
BD - Bangladesh 4
CO - Colombia 4
MD - Moldavia 4
MY - Malesia 4
NO - Norvegia 4
SA - Arabia Saudita 4
BF - Burkina Faso 3
IQ - Iraq 3
IS - Islanda 3
LT - Lituania 3
LU - Lussemburgo 3
AL - Albania 2
AM - Armenia 2
JO - Giordania 2
KH - Cambogia 2
OM - Oman 2
TG - Togo 2
TH - Thailandia 2
UG - Uganda 2
UY - Uruguay 2
YE - Yemen 2
AE - Emirati Arabi Uniti 1
BO - Bolivia 1
BY - Bielorussia 1
EU - Europa 1
GL - Groenlandia 1
KE - Kenya 1
KZ - Kazakistan 1
LI - Liechtenstein 1
MT - Malta 1
MU - Mauritius 1
PE - Perù 1
QA - Qatar 1
RE - Reunion 1
SC - Seychelles 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
Totale 6.581
Salva come PNG Salva come JPEG
Città #
Leawood 254
Falls Church 200
Nürnberg 193
New York 171
Ashburn 64
Polska 55
Houston 53
Fairfield 51
Jakarta 45
Shanghai 41
Ann Arbor 32
Wilmington 32
Milan 30
Santa Cruz 30
Torino 29
Seattle 28
Helsinki 27
Jinan 27
Woodbridge 27
Maikammer 26
Wenzhou 26
Dong Ket 25
Hyderabad 25
Wuhan 25
Buffalo 23
Turin 22
Naaldwijk 21
Seoul 20
Warsaw 20
Cambridge 19
Frankfurt am Main 18
Tokyo 18
Athens 17
Landshut 17
Amsterdam 16
Boardman 16
Bologna 16
Chennai 16
Johannesburg 15
Madrid 15
Rome 15
Bengaluru 14
San Francisco 14
Singapore 14
Chaoyang 13
Delhi 13
Fuzhou 13
Gurgaon 13
Indore 13
Richmond 13
San Jose 13
Taipei 13
Beijing 12
Bucharest 12
Guangzhou 12
Los Angeles 12
Moncalieri 12
Chicago 11
Duncan 11
Parsippany 11
Bad Kreuznach 10
Lodz 10
Munich 10
Naples 10
Palermo 10
San Diego 10
Zagreb 10
Bedford 9
Central District 9
Hamadacho 9
London 9
Mountain View 9
Ottawa 9
San Mateo 9
Sezze 9
Shenyang 9
Stockholm 9
Udine 9
Berlin 8
Kumar 8
Medford 8
Oxford 8
Serres 8
Suri 8
Tettnang 8
Toronto 8
Washington 8
Central 7
Council Bluffs 7
Mysore 7
Pisa 7
Zurich 7
Castelnuovo Bozzente 6
Dublin 6
Durham 6
Islamabad 6
Kraków 6
Lausanne 6
Longueuil 6
Monmouth Junction 6
Totale 2.383
Salva come PNG Salva come JPEG
Nome #
Emerging therapies for acute myeloid leukaemia using hDHODH inhibitors able to restore in vitro and in vivo myeloid differentiation, file e27ce42e-e3ed-2581-e053-d805fe0acbaa 4.586
Emerging therapies for acute myeloid leukaemia using hDHODH inhibitors, file e27ce42e-e3f2-2581-e053-d805fe0acbaa 1.371
Improvement of in vivo pharmacokinetic profile of M433, a potent and innovative hDHODH inhibitor., file e27ce42f-3286-2581-e053-d805fe0acbaa 366
miR-223 is a coordinator of breast cancer progression as revealed by bioinformatics predictions, file e27ce428-f2d7-2581-e053-d805fe0acbaa 153
The synergism between DHODH inhibitors and dipyridamole leads to metabolic lethality in acute myeloid leukemia, file e27ce432-269b-2581-e053-d805fe0acbaa 141
Investigation of the central core of MEDS433: A Bioisosteric voyage into the Amide's Role., file b671f2a7-d375-46b9-a955-083bbb561111 139
Nanocarriers as magic bullets in the treatment of leukemia, file e27ce430-bb59-2581-e053-d805fe0acbaa 120
Inhibition of bromodomain and extra-terminal proteins increases sensitivity to venetoclax in chronic lymphocytic leukaemia, file e27ce42f-2687-2581-e053-d805fe0acbaa 102
PROCEEDINGS OF THE MERCK & ELSEVIER YOUNG CHEMISTSSYMPOSIUM, file e27ce42d-c4a1-2581-e053-d805fe0acbaa 79
Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors, file e27ce433-402c-2581-e053-d805fe0acbaa 47
Meds433, a New Dihydroorotate Dehydrogenase Inhibitor, Induces Apoptosis and Differentiation in Acute Myeloid Leukemia, file e27ce434-529c-2581-e053-d805fe0acbaa 41
A differentiating and apoptotic therapy for acute myeloid leukaemia using potent human dihydroorotate dehydrogenase inhibitors., file e27ce42e-f84b-2581-e053-d805fe0acbaa 34
In vitro myeloid differentiation using a new generation of potent human dihydroorotate dehydrogenase inhibitors, file e27ce42d-bf81-2581-e053-d805fe0acbaa 33
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Aryloxyaryl Moiety, file 33b0c0fc-4948-4f36-822a-38bf37292599 27
Identification of a new subclass of ALK negative ALCL expressing aberrant levels of ERBB4 transcripts, file e27ce42b-e85e-2581-e053-d805fe0acbaa 20
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold: SAR of the Biphenyl Moiety, file e27ce432-fd74-2581-e053-d805fe0acbaa 20
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold: SAR of the Biphenyl Moiety, file e27ce432-bb56-2581-e053-d805fe0acbaa 19
Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti-leukaemic potential and alloreactivity across major human leukocyte antigen barriers, file f00758c0-2499-463a-8fb2-6d2bebb49288 17
Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors, file e27ce42d-ad8b-2581-e053-d805fe0acbaa 6
Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms, file e27ce42e-2c4c-2581-e053-d805fe0acbaa 6
In vitro myeloid differentiation using a new generation of potent human dihydroorotate dehydrogenase inhibitors, file e27ce42d-9ae6-2581-e053-d805fe0acbaa 5
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold: SAR of the Biphenyl Moiety, file e27ce432-bcf1-2581-e053-d805fe0acbaa 5
High Basal γH2AX Levels Sustain Self-Renewal of Mouse Embryonic and Induced Pluripotent Stem Cells., file e27ce426-d2a2-2581-e053-d805fe0acbaa 3
In vitro myeloid differentiation using a new generation of potent human dihydroorotate dehydrogenase (hDHODH) inhibitors, file e27ce42d-2659-2581-e053-d805fe0acbaa 3
In vitro myeloid differentiation using a new generation of potent human dihydroorotate dehydrogenase (hDHODH) inhibitors, file e27ce42d-2aec-2581-e053-d805fe0acbaa 3
DHODH inhibitors and leukemia: an emergent interest for new myeloid differentiation agents, file e27ce42d-4cce-2581-e053-d805fe0acbaa 3
Survivin-peptide vaccination elicits immune response after allogeneic nonmyeloablative transplantation: a safe strategy to enhance the graft versus tumor effect, file e27ce42e-7b6d-2581-e053-d805fe0acbaa 3
Targeting myeloid differentiation using potent human dihydroorotate dehydrogenase (hDHODH) inhibitors, file e27ce42c-f112-2581-e053-d805fe0acbaa 2
Targeting Acute Myelogenous Leukemia using potent human dihydroorotate dehydrogenase inhibitors based on the 2-hydroxypyrazolo[1,5-a]pyridine scaffold: from academy to clinic, file 0f183a53-b692-48a9-996c-fc7c1c008917 1
Improvement of Metabolic Weakness of New Dihydroorotate Dehydrogenase Inhibitors Based on 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold to Target Myeloid Leukemias, file 83388e83-ad81-4a04-93f3-2b0624b87ea4 1
Important Steps into Drug Development of MEDS433, a Potent Human Dihydroorotate Dehydrogenase Inhibitor based on the 2-hydroxypyrazolo[1,5-a] Pyridine Scaffold, file ba92237a-a9d9-4a82-8262-6f5eaf4c9219 1
Investigation of the central core of MEDS433: A Bioisosteric voyage into the Amide's Role, file de2f6890-765d-4b86-8326-f3677ffc1aed 1
Development of Potent Human Dihydroorotate Dehydrogenase Inhibitors Able to Induces Myeloid Differentiation, file e27ce42c-bb7d-2581-e053-d805fe0acbaa 1
Development of Potent Human Dihydroorotate Dehydrogenase Inhibitors Able to Induces Myeloid Differentiation, file e27ce42c-bb7e-2581-e053-d805fe0acbaa 1
Apoptotic and differentiating therapy for AML using potent human dihydroorotate dehydrogenase inhibitor, file e27ce434-f61f-2581-e053-d805fe0acbaa 1
Totale 7.361
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.899
article - articoli 0
book - libri 0
conference - conferenze 8.354
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.253
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201930 0 0 0 0 0 0 0 0 0 5 17 8
2019/20201.043 3 8 5 10 6 2 263 127 77 171 186 185
2020/20212.271 146 120 155 211 156 163 243 221 206 189 309 152
2021/20222.276 188 181 192 205 181 138 151 134 171 187 387 161
2022/20231.277 129 202 172 147 144 92 64 96 81 59 64 27
2023/2024414 17 21 47 50 39 25 126 61 16 12 0 0
Totale 7.361